Related Experiment Video
Updated: Mar 1, 2026

Isolation of Human Primary Valve Cells for In vitro Disease Modeling
Published on: April 16, 2021
Genetic Insights Into Bicuspid Aortic Valve Disease
Radoslaw Debiec1, Hanish Sall, Nilesh J Samani
1From the *Leicester Cardiovascular Biomedical Research Unit, Department of Cardiovascular Sciences, University of Leicester, Glenfield General Hospital, Leicester, United Kingdom; †Department of Cardiology, University of Leicester, Northhampton General Hospital, Northhampton, United Kingdom; and ‡Department of Cardiovascular Sciences, University of Leicester, East Midlands Congenital Heart Centre, Glenfield General Hospital, Leicester, United Kingdom.
Bicuspid aortic valve (BAV) is a common congenital heart defect. Genetic studies identify BAV-associated genes, but replication and functional validation remain challenging due to disease heterogeneity.
Area of Science:
- Cardiology
- Genetics
- Developmental Biology
Background:
- Bicuspid aortic valve (BAV) is the most prevalent congenital heart defect.
- BAV frequently co-occurs with other cardiovascular malformations, leading to significant surgical intervention rates.
- Familial aggregation of BAV supports a genetic component, prompting screening recommendations for relatives.
Purpose of the Study:
- To provide an overview of published genetic linkage studies associated with BAV.
- To discuss the challenges in BAV genetic research, including phenotypic and genetic heterogeneity.
- To highlight the potential clinical impact of understanding BAV molecular pathology.
Main Methods:
- Review of published literature on genetic linkage and association studies in BAV.
- Analysis of diverse discovery strategies, from candidate gene association to whole exome sequencing.
- Consideration of various validation protocols and their limitations.
Main Results:
- Multiple genetic loci and candidate genes implicated in BAV development have been identified.
- Replication of findings across populations and functional validation in animal models remain limited.
- Phenotypic heterogeneity, including varying valve fusion patterns, complicates genetic analysis.
Conclusions:
- Understanding the genetic basis of BAV is crucial for clinical applications.
- Advances in next-generation sequencing and bioinformatics facilitate BAV genetic research.
- Future research will enable genetic counseling, prenatal diagnosis, and improved risk stratification for BAV patients.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Incomplete Dominance

